Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report
With the arrival of a new generation of oral anticoagulants significant burdens associated with warfarin’s use on both the patient and the healthcare system have been alleviated. Nevertheless, a shortfall exists in regard to an agent or protocol for reversal of these new anticoagulants in the setti...
Saved in:
Main Authors: | Naveen Nannapaneni, Robby Singh, Paulina Mckay, Marwan Al-Hajeili |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2014/548272 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01) -
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
by: Muhammed Sherid, et al.
Published: (2016-01-01) -
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
by: Olivia Wu, et al.
Published: (2022-01-01) -
Influence of novel oral anticoagulants on anticoagulation care management
by: Janzic Andrej, et al.
Published: (2017-09-01)